| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 9.82e-10 | 7 | 174 | 5 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 9.82e-10 | 7 | 174 | 5 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.15e-08 | 10 | 174 | 5 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.15e-08 | 10 | 174 | 5 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.15e-08 | 10 | 174 | 5 | GO:0102033 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 2.77e-08 | 5 | 174 | 4 | GO:0052871 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 5.77e-08 | 13 | 174 | 5 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.76e-06 | 24 | 174 | 5 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 3.28e-06 | 27 | 174 | 5 | GO:0008391 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 4.12e-06 | 49 | 174 | 6 | GO:0016712 | |
| GeneOntologyMolecularFunction | arachidonate binding | 7.05e-06 | 15 | 174 | 4 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 9.34e-06 | 16 | 174 | 4 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 9.34e-06 | 16 | 174 | 4 | GO:0050543 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.25e-05 | 35 | 174 | 5 | GO:0070330 | |
| GeneOntologyMolecularFunction | prolactin receptor binding | 2.22e-05 | 7 | 174 | 3 | GO:0005148 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.44e-05 | 40 | 174 | 5 | GO:0016709 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXO3 NCOA3 TBX3 ZNF473 ZNF423 ZNF329 ZBTB22 SOX17 MLXIP ZNF236 ZNF865 CLOCK CREB5 ZFY STK16 ZNF711 HINFP ZNF668 WIZ ZNF425 ZNF408 ZNF197 ZFHX3 ATOH1 ZNF582 EP300 ZNF646 FOXP3 | 6.35e-05 | 1459 | 174 | 28 | GO:0000977 |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 7.46e-05 | 10 | 174 | 3 | GO:0005131 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 7.55e-05 | 2 | 174 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 7.55e-05 | 2 | 174 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 9.68e-05 | 28 | 174 | 4 | GO:0036041 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXO3 TBX3 ZNF473 ZNF423 ZBTB22 SOX17 MLXIP ZNF236 ZNF865 CLOCK CREB5 ZFY STK16 ZNF711 HINFP ZNF668 WIZ ZNF408 ZNF197 ZFHX3 ATOH1 EP300 ZNF646 FOXP3 | 2.08e-04 | 1244 | 174 | 24 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXO3 NCOA3 TBX3 ZNF473 ZNF423 ZNF329 ZBTB22 SOX17 SAMD7 MLXIP ZNF236 CLOCK CREB5 ZFY ZNF711 HINFP ZNF668 WIZ ZNF425 ZNF408 ZNF197 ZFHX3 ATOH1 ZNF582 ZNF646 FOXP3 | 2.31e-04 | 1412 | 174 | 26 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXO3 TBX3 ZNF473 ZNF423 ZBTB22 SOX17 MLXIP ZNF236 ZNF865 CLOCK CREB5 ZFY STK16 ZNF711 HINFP ZNF668 WIZ ZNF408 ZNF197 ZFHX3 ATOH1 EP300 ZNF646 FOXP3 | 2.85e-04 | 1271 | 174 | 24 | GO:0000987 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3.08e-04 | 194 | 174 | 8 | GO:0016705 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FOXO3 NCOA3 TBX3 ZNF473 SOX17 MLXIP CLOCK CREB5 ZFY HINFP ZNF668 ZNF197 ATOH1 FOXP3 | 4.08e-04 | 560 | 174 | 14 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FOXO3 NCOA3 TBX3 ZNF473 SOX17 MLXIP CLOCK CREB5 ZFY HINFP ZNF668 ZNF197 ATOH1 FOXP3 | 4.53e-04 | 566 | 174 | 14 | GO:0001216 |
| GeneOntologyMolecularFunction | monooxygenase activity | 5.16e-04 | 115 | 174 | 6 | GO:0004497 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 7.42e-04 | 5 | 174 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | transcription factor binding | FOXO3 NCOA3 STK36 TBX3 ZNF473 CENPF SOX17 CLOCK CIT NCAPG2 WIZ BBS7 NR0B1 NCOA7 EP300 FOXP3 | 9.30e-04 | 753 | 174 | 16 | GO:0008134 |
| GeneOntologyMolecularFunction | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity | 1.11e-03 | 6 | 174 | 2 | GO:0001665 | |
| GeneOntologyMolecularFunction | dynein complex binding | 1.82e-03 | 28 | 174 | 3 | GO:0070840 | |
| GeneOntologyMolecularFunction | chromatin binding | MKRN4P FOXO3 NCOA3 TICRR CENPF IFT74 POLE MKRN1 TSPYL6 SAMD7 CLOCK ZFY HINFP ATOH1 EP300 | 2.09e-03 | 739 | 174 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | heme binding | 2.33e-03 | 154 | 174 | 6 | GO:0020037 | |
| GeneOntologyMolecularFunction | protein kinase activity | STK36 HIPK4 CDK15 ROR1 ROR2 STYK1 TEX14 CIT STK16 MAP3K11 PRKCZ MAP3K13 TSSK1B | 2.36e-03 | 600 | 174 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | kinase activity | STK36 HIPK4 CDK15 ROR1 ROR2 STYK1 TEX14 CIT AK8 STK16 MAP3K11 PIP5K1A PRKCZ MAP3K13 TSSK1B | 2.87e-03 | 764 | 174 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | fatty acid binding | 3.10e-03 | 69 | 174 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 3.19e-03 | 164 | 174 | 6 | GO:0046906 | |
| GeneOntologyMolecularFunction | hormone receptor binding | 3.19e-03 | 34 | 174 | 3 | GO:0051427 | |
| GeneOntologyMolecularFunction | iron ion binding | 3.38e-03 | 166 | 174 | 6 | GO:0005506 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | STK36 HIPK4 CDK15 POLE ROR1 ROR2 STYK1 POLRMT TEX14 CIT AK8 STK16 MAP3K11 PIP5K1A PRKCZ MAP3K13 TSSK1B | 3.49e-03 | 938 | 174 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | STK36 HIPK4 CDK15 ROR1 ROR2 STYK1 TEX14 CIT STK16 MAP3K11 PIP5K1A PRKCZ MAP3K13 TSSK1B | 3.75e-03 | 709 | 174 | 14 | GO:0016773 |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 7.08e-08 | 6 | 173 | 4 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 1.64e-07 | 7 | 173 | 4 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 3.26e-07 | 8 | 173 | 4 | GO:0036100 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 5.80e-07 | 3 | 173 | 3 | GO:0042361 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 1.51e-06 | 11 | 173 | 4 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 2.25e-06 | 12 | 173 | 4 | GO:0042758 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 2.31e-06 | 4 | 173 | 3 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 2.31e-06 | 4 | 173 | 3 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 2.31e-06 | 4 | 173 | 3 | GO:0042377 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 2.31e-06 | 4 | 173 | 3 | GO:0009233 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 4.48e-06 | 14 | 173 | 4 | GO:0097267 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 8.59e-06 | 87 | 173 | 7 | GO:0033143 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 1.14e-05 | 6 | 173 | 3 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 1.14e-05 | 6 | 173 | 3 | GO:0062232 | |
| GeneOntologyBiologicalProcess | gamete generation | FOXO3 DNHD1 RHBDD1 DMXL2 ARMC3 CNTRL SOX17 FANCL APOB PIWIL2 TEX14 MEI1 SSX1 CLOCK CIT ZFY NR0B1 SEPTIN1 ZPBP2 DLEC1 TSSK1B BAG6 | 2.61e-05 | 982 | 173 | 22 | GO:0007276 |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 3.11e-05 | 22 | 173 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | sexual reproduction | FOXO3 DNHD1 RHBDD1 DMXL2 ARMC3 CNTRL SOX17 FANCL APOB PIWIL2 TEX14 MEI1 SSX1 CLOCK CIT ADCY3 ZFY UMODL1 NR0B1 SEPTIN1 ZPBP2 DLEC1 TSSK1B BAG6 CPEB1 NLRP5 | 3.77e-05 | 1312 | 173 | 26 | GO:0019953 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | CENPF CEP192 TEX14 MEI1 CIT NCAPG2 KIF15 TRAPPC12 SEPTIN1 FAM83D BAG6 CPEB1 | 4.91e-05 | 356 | 173 | 12 | GO:0098813 |
| GeneOntologyBiologicalProcess | prophase | 6.66e-05 | 10 | 173 | 3 | GO:0051324 | |
| GeneOntologyBiologicalProcess | meiotic prophase I | 6.66e-05 | 10 | 173 | 3 | GO:0007128 | |
| GeneOntologyBiologicalProcess | male gamete generation | DNHD1 RHBDD1 DMXL2 ARMC3 SOX17 APOB PIWIL2 TEX14 MEI1 SSX1 CLOCK CIT ZFY NR0B1 ZPBP2 DLEC1 TSSK1B BAG6 | 7.63e-05 | 762 | 173 | 18 | GO:0048232 |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 9.11e-05 | 11 | 173 | 3 | GO:0042373 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | MAN2A1 WNT2 TSC2 XRCC5 CIT GH1 SLIT2 CSH1 CSH2 SLIT1 LRP4 MAP3K13 ATOH1 EP300 | 1.18e-04 | 515 | 173 | 14 | GO:0050767 |
| GeneOntologyBiologicalProcess | meiosis I cell cycle phase | 1.21e-04 | 12 | 173 | 3 | GO:0098764 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 1.21e-04 | 12 | 173 | 3 | GO:0042363 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.52e-04 | 136 | 173 | 7 | GO:0030518 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid hormone biosynthetic process | 1.56e-04 | 13 | 173 | 3 | GO:0090031 | |
| GeneOntologyBiologicalProcess | embryo development | NCOA3 TBX3 MAN2A1 MYO7A WNT2 POLE DZIP1L ROR2 SOX17 AMBRA1 TSC2 APOB NCAPG2 ZFY HINFP SLIT2 PLPP3 BBS7 NR0B1 MIB1 LRP4 ATOH1 ATP2B2 BAG6 EP300 NLRP5 | 1.67e-04 | 1437 | 173 | 26 | GO:0009790 |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | FOXO3 DNHD1 RHBDD1 DMXL2 ARMC3 CNTRL SOX17 FANCL APOB PIWIL2 TEX14 MEI1 SSX1 CLOCK CIT ZFY UMODL1 NR0B1 SEPTIN1 ZPBP2 DLEC1 TSSK1B BAG6 | 1.68e-04 | 1194 | 173 | 23 | GO:0048609 |
| GeneOntologyBiologicalProcess | cell cycle process | TICRR NUGGC CENPF POLE AMBRA1 PIWIL2 CEP192 TEX14 MEI1 CLOCK CIT NCAPG2 TTC19 ZFY HINFP WIZ KIF15 TRAPPC12 SEPTIN1 MAP3K11 FAM83D CSPP1 MN1 BAG6 CPEB1 NLRP5 | 1.74e-04 | 1441 | 173 | 26 | GO:0022402 |
| GeneOntologyBiologicalProcess | spermatogenesis | DNHD1 RHBDD1 DMXL2 ARMC3 SOX17 APOB PIWIL2 MEI1 SSX1 CLOCK CIT ZFY NR0B1 ZPBP2 DLEC1 TSSK1B BAG6 | 1.81e-04 | 744 | 173 | 17 | GO:0007283 |
| GeneOntologyBiologicalProcess | meiotic cell cycle phase | 1.97e-04 | 14 | 173 | 3 | GO:0098762 | |
| GeneOntologyBiologicalProcess | M phase | 1.97e-04 | 14 | 173 | 3 | GO:0000279 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 2.09e-04 | 3 | 173 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle atrophy | 2.09e-04 | 3 | 173 | 2 | GO:0014737 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 2.66e-04 | 68 | 173 | 5 | GO:0019369 | |
| GeneOntologyBiologicalProcess | head development | FOXO3 STK36 TBX3 DMXL2 CENPF WNT2 ZNF423 PFAS AK8 CHRNB2 SLIT2 BBS7 SLIT1 NR0B1 ATOH1 GMPPA ATP2B2 BAG6 EP300 | 2.69e-04 | 919 | 173 | 19 | GO:0060322 |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 2.72e-04 | 106 | 173 | 6 | GO:0050810 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | FOXO3 DNHD1 NCOA3 RHBDD1 TBX3 DMXL2 ARMC3 CNTRL ROR2 SOX17 APOB PIWIL2 MEI1 SSX1 CLOCK CIT ZFY UMODL1 NR0B1 ZPBP2 DLEC1 TSSK1B BAG6 | 2.73e-04 | 1235 | 173 | 23 | GO:0003006 |
| GeneOntologyBiologicalProcess | sensory perception of sound | 2.74e-04 | 198 | 173 | 8 | GO:0007605 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid biosynthetic process | 2.82e-04 | 38 | 173 | 4 | GO:0010893 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 3.14e-04 | 202 | 173 | 8 | GO:0141193 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.40e-04 | 155 | 173 | 7 | GO:0043401 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 3.71e-04 | 73 | 173 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 3.80e-04 | 41 | 173 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 4.15e-04 | 4 | 173 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid metabolic process | 4.17e-04 | 42 | 173 | 4 | GO:0045940 | |
| GeneOntologyBiologicalProcess | vitamin catabolic process | 4.31e-04 | 18 | 173 | 3 | GO:0009111 | |
| GeneOntologyBiologicalProcess | central nervous system development | FOXO3 STK36 TBX3 DMXL2 MYCBP2 CENPF WNT2 ZNF423 ROR1 ROR2 AK8 CHRNB2 SLIT2 PLPP3 BBS7 SLIT1 NR0B1 ATOH1 GMPPA ATP2B2 BAG6 FOXP3 | 4.47e-04 | 1197 | 173 | 22 | GO:0007417 |
| GeneOntologyBiologicalProcess | positive regulation of hormone biosynthetic process | 5.09e-04 | 19 | 173 | 3 | GO:0046886 | |
| GeneOntologyBiologicalProcess | chromosome segregation | CENPF CEP192 TEX14 MEI1 CIT NCAPG2 KIF15 TRAPPC12 SEPTIN1 FAM83D BAG6 CPEB1 | 5.77e-04 | 465 | 173 | 12 | GO:0007059 |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 5.78e-04 | 122 | 173 | 6 | GO:0051303 | |
| GeneOntologyBiologicalProcess | regulation of response to nutrient levels | 5.93e-04 | 46 | 173 | 4 | GO:0032107 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 6.35e-04 | 82 | 173 | 5 | GO:1901568 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 6.88e-04 | 5 | 173 | 2 | GO:0021831 | |
| GeneOntologyBiologicalProcess | regulation of muscle atrophy | 6.88e-04 | 5 | 173 | 2 | GO:0014735 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 6.90e-04 | 21 | 173 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | FOXO3 MAN2A1 WNT2 ROR2 AMBRA1 XRCC5 GH1 SLIT2 CSH1 CSH2 PRKCZ MAP3K13 EP300 FOXP3 | 6.94e-04 | 614 | 173 | 14 | GO:0010720 |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 7.44e-04 | 128 | 173 | 6 | GO:0033559 | |
| GeneOntologyBiologicalProcess | chromosome localization | 8.07e-04 | 130 | 173 | 6 | GO:0050000 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | MAN2A1 WNT2 TSC2 XRCC5 CIT GH1 SLIT2 CSH1 CSH2 SLIT1 LRP4 MAP3K13 ATOH1 EP300 | 8.24e-04 | 625 | 173 | 14 | GO:0051960 |
| GeneOntologyBiologicalProcess | regulation of cell development | FOXO3 MAN2A1 WNT2 ROR2 AMBRA1 TSC2 XRCC5 CLOCK CIT GH1 SLIT2 CSH1 CSH2 SLIT1 LRP4 PRKCZ MAP3K13 ATOH1 EP300 FOXP3 | 8.89e-04 | 1095 | 173 | 20 | GO:0060284 |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 9.23e-04 | 238 | 173 | 8 | GO:0050954 | |
| GeneOntologyBiologicalProcess | brain development | FOXO3 STK36 TBX3 DMXL2 CENPF WNT2 ZNF423 AK8 CHRNB2 SLIT2 BBS7 SLIT1 NR0B1 ATOH1 GMPPA ATP2B2 BAG6 | 9.26e-04 | 859 | 173 | 17 | GO:0007420 |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 9.48e-04 | 239 | 173 | 8 | GO:0071383 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 9.83e-04 | 135 | 173 | 6 | GO:0019218 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell stereocilium organization | 1.02e-03 | 53 | 173 | 4 | GO:0060122 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 1.03e-03 | 6 | 173 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | leptotene | 1.03e-03 | 6 | 173 | 2 | GO:0000237 | |
| GeneOntologyBiologicalProcess | regulation of steroid hormone biosynthetic process | 1.03e-03 | 24 | 173 | 3 | GO:0090030 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.08e-03 | 244 | 173 | 8 | GO:0009755 | |
| GeneOntologyCellularComponent | growth hormone receptor complex | 1.06e-05 | 6 | 171 | 3 | GO:0070195 | |
| GeneOntologyCellularComponent | cilium | DNHD1 TBX3 FBXL13 CENPF MYO7A IFT74 DZIP1L CNTRL EVC AMBRA1 ADGRV1 SSX1 ADCY3 AK8 BBS7 ELMOD3 DLEC1 TSSK1B ATP2B2 | 1.45e-04 | 898 | 171 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | meiotic spindle | 4.73e-04 | 19 | 171 | 3 | GO:0072687 | |
| GeneOntologyCellularComponent | midbody | 4.98e-04 | 222 | 171 | 8 | GO:0030496 | |
| GeneOntologyCellularComponent | microtubule organizing center | FBXL13 TTC28 CENPF IFT74 DZIP1L CNTRL EVC CEP192 TTC19 KIF15 BBS7 NR0B1 MIB1 SEPTIN1 MAP3K11 PRKCZ CSPP1 CPEB1 | 5.50e-04 | 919 | 171 | 18 | GO:0005815 |
| MousePheno | advanced circadian behavior phase | 8.12e-06 | 5 | 132 | 3 | MP:0020474 | |
| MousePheno | persistence of hyaloid vascular system | NCOA3 MYO7A CYP7A1 ZNF423 ROR2 CYP4F2 CHRNB2 CYP4F12 FGD5 PRKCZ CYP4F11 | 8.49e-06 | 223 | 132 | 11 | MP:0001289 |
| MousePheno | abnormal distortion product otoacoustic emission | 1.53e-05 | 85 | 132 | 7 | MP:0004736 | |
| MousePheno | abnormal otoacoustic response | 1.65e-05 | 86 | 132 | 7 | MP:0006336 | |
| MousePheno | abnormal male reproductive system physiology | DNHD1 TPTE STK36 TBX3 HIPK4 ARMC3 LKAAEAR1 MYO7A ROR2 FANCL APOB PIWIL2 TEX14 MEI1 XRCC5 CIT ADCY3 GH1 CSH1 CSH2 BBS7 NR0B1 PIP5K1A ZPBP2 DLEC1 CCDC183 CPEB1 FOXP3 | 3.82e-05 | 1329 | 132 | 28 | MP:0003698 |
| MousePheno | abnormal outer hair cell stereociliary bundle morphology | 4.29e-05 | 68 | 132 | 6 | MP:0004527 | |
| MousePheno | decreased pituitary gland weight | 4.45e-05 | 8 | 132 | 3 | MP:0008938 | |
| MousePheno | abnormal vitreous body morphology | NCOA3 MAN2A1 MYO7A CYP7A1 ZNF423 ROR2 CYP4F2 CHRNB2 SLIT2 NUP210 CYP4F12 FGD5 PRKCZ CYP4F11 | 5.37e-05 | 429 | 132 | 14 | MP:0002699 |
| MousePheno | absent somatotrophs | 6.63e-05 | 9 | 132 | 3 | MP:0008330 | |
| MousePheno | absent lactotrophs | 6.63e-05 | 9 | 132 | 3 | MP:0008333 | |
| MousePheno | absent cochlear hair bundle ankle links | 8.85e-05 | 2 | 132 | 2 | MP:0004582 | |
| MousePheno | abnormal cochlear hair bundle ankle links morphology | 8.85e-05 | 2 | 132 | 2 | MP:0004581 | |
| MousePheno | abnormal spermatogenesis | DNHD1 TPTE HIPK4 ARMC3 ROR2 FANCL APOB PIWIL2 TEX14 MEI1 CIT ADCY3 ZFY BBS7 NR0B1 PIP5K1A ZPBP2 DLEC1 CCDC183 CPEB1 FOXP3 | 1.20e-04 | 910 | 132 | 21 | MP:0001156 |
| MousePheno | delayed vaginal opening | 1.30e-04 | 28 | 132 | 4 | MP:0002636 | |
| MousePheno | abnormal male germ cell morphology | DNHD1 TPTE HIPK4 ARMC3 ROR2 FANCL APOB PIWIL2 TEX14 MEI1 CIT ZFY BBS7 NR0B1 PIP5K1A ZPBP2 DLEC1 CCDC183 CPEB1 FOXP3 | 1.57e-04 | 859 | 132 | 20 | MP:0006362 |
| MousePheno | increased circulating ghrelin level | 1.70e-04 | 12 | 132 | 3 | MP:0011612 | |
| MousePheno | abnormal pituitary gland weight | 1.70e-04 | 12 | 132 | 3 | MP:0008937 | |
| MousePheno | small liver | NCOA3 TBX3 ZBTB22 SOX17 TSC2 ZNF236 GH1 CSH1 CSH2 NUP210 FGD5 | 1.96e-04 | 315 | 132 | 11 | MP:0000601 |
| MousePheno | abnormal timing of vaginal opening | 1.96e-04 | 31 | 132 | 4 | MP:0020150 | |
| MousePheno | cochlear inner hair cell degeneration | 1.97e-04 | 57 | 132 | 5 | MP:0004398 | |
| MousePheno | abnormal germ cell morphology | FOXO3 DNHD1 TPTE HIPK4 ARMC3 ROR2 FANCL APOB PIWIL2 TEX14 MEI1 CIT ZFY BBS7 NR0B1 PIP5K1A ZPBP2 DLEC1 CCDC183 CPEB1 FOXP3 | 2.05e-04 | 946 | 132 | 21 | MP:0002208 |
| MousePheno | abnormal cochlear hair cell stereociliary bundle morphology | 2.19e-04 | 91 | 132 | 6 | MP:0004521 | |
| MousePheno | abnormal foam cell morphology | FOXO3 DNHD1 TPTE HIPK4 ARMC3 ROR2 FANCL APOB PIWIL2 TEX14 MEI1 CIT ZFY BBS7 NR0B1 PIP5K1A ZPBP2 DLEC1 CCDC183 CPEB1 FOXP3 | 2.30e-04 | 954 | 132 | 21 | MP:0009840 |
| MousePheno | infertility | FOXO3 DNHD1 STK36 HIPK4 ARMC3 LKAAEAR1 MYO7A EVC FANCL PIWIL2 TEX14 MEI1 XRCC5 GH1 CSH1 CSH2 BBS7 NR0B1 DLEC1 CCDC183 ATP2B2 CPEB1 NLRP5 FOXP3 | 2.85e-04 | 1188 | 132 | 24 | MP:0001924 |
| MousePheno | abnormal circulating ghrelin level | 3.45e-04 | 15 | 132 | 3 | MP:0011611 | |
| MousePheno | abnormal gametogenesis | FOXO3 DNHD1 TPTE HIPK4 ARMC3 ROR2 FANCL APOB PIWIL2 TEX14 MEI1 CIT ADCY3 ZFY BBS7 NR0B1 PIP5K1A ZPBP2 DLEC1 CCDC183 CPEB1 FOXP3 | 4.16e-04 | 1070 | 132 | 22 | MP:0001929 |
| MousePheno | abnormal susceptibility to hearing loss | 4.37e-04 | 38 | 132 | 4 | MP:0006334 | |
| MousePheno | cochlear hair cell degeneration | 4.99e-04 | 106 | 132 | 6 | MP:0004362 | |
| MousePheno | decreased lactotroph cell number | 5.08e-04 | 17 | 132 | 3 | MP:0008332 | |
| MousePheno | abnormal diencephalon morphology | 5.26e-04 | 298 | 132 | 10 | MP:0000830 | |
| Domain | ZINC_FINGER_C2H2_2 | ZXDC ZNF473 ZNF423 DZIP1L ZNF329 ZBTB22 CPXCR1 ZNF236 ZNF865 CREB5 ZFY ZNF711 HINFP ZNF668 WIZ ZNF425 ZNF408 ZNF197 ZFHX3 ZNF582 ZNF646 FOXP3 | 3.00e-06 | 775 | 173 | 22 | PS50157 |
| Domain | Znf_C2H2-like | ZXDC ZNF473 ZNF423 DZIP1L ZNF329 ZBTB22 CPXCR1 ZNF236 ZNF865 CREB5 ZFY ZNF711 HINFP ZNF668 WIZ ZNF425 ZNF408 ZNF197 ZFHX3 ZNF582 ZNF646 FOXP3 | 4.61e-06 | 796 | 173 | 22 | IPR015880 |
| Domain | Znf_C2H2 | ZXDC ZNF473 ZNF423 DZIP1L ZNF329 ZBTB22 CPXCR1 ZNF236 ZNF865 CREB5 ZFY ZNF711 HINFP ZNF668 WIZ ZNF425 ZNF408 ZNF197 ZFHX3 ZNF582 ZNF646 FOXP3 | 5.51e-06 | 805 | 173 | 22 | IPR007087 |
| Domain | ZnF_C2H2 | ZXDC ZNF473 ZNF423 DZIP1L ZNF329 ZBTB22 CPXCR1 ZNF236 ZNF865 CREB5 ZFY ZNF711 HINFP ZNF668 WIZ ZNF425 ZNF408 ZNF197 ZFHX3 ZNF582 ZNF646 FOXP3 | 5.84e-06 | 808 | 173 | 22 | SM00355 |
| Domain | Cyt_P450_CS | 9.27e-06 | 53 | 173 | 6 | IPR017972 | |
| Domain | ZINC_FINGER_C2H2_1 | ZXDC ZNF473 ZNF423 DZIP1L ZNF329 ZBTB22 ZNF236 ZNF865 CREB5 ZFY ZNF711 HINFP ZNF668 WIZ ZNF425 ZNF408 ZNF197 ZFHX3 ZNF582 ZNF646 FOXP3 | 1.08e-05 | 777 | 173 | 21 | PS00028 |
| Domain | CYTOCHROME_P450 | 1.42e-05 | 57 | 173 | 6 | PS00086 | |
| Domain | SOMATOTROPIN_2 | 1.53e-05 | 6 | 173 | 3 | PS00338 | |
| Domain | SOMATOTROPIN_1 | 1.53e-05 | 6 | 173 | 3 | PS00266 | |
| Domain | Hormone_1 | 1.53e-05 | 6 | 173 | 3 | PF00103 | |
| Domain | - | 1.57e-05 | 58 | 173 | 6 | 1.10.630.10 | |
| Domain | p450 | 1.57e-05 | 58 | 173 | 6 | PF00067 | |
| Domain | - | ZXDC ZNF473 ZNF423 ZNF329 ZBTB22 ZNF236 ZNF865 CREB5 ZFY ZNF711 HINFP ZNF668 ZNF425 ZNF408 ZNF197 ZFHX3 ZNF582 ZNF646 FOXP3 | 1.82e-05 | 679 | 173 | 19 | 3.30.160.60 |
| Domain | Cyt_P450 | 1.92e-05 | 60 | 173 | 6 | IPR001128 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZXDC ZNF473 ZNF423 ZNF329 ZBTB22 ZNF236 ZNF865 CREB5 ZFY ZNF711 HINFP ZNF668 ZNF425 ZNF408 ZNF197 ZFHX3 ZNF582 ZNF646 FOXP3 | 2.46e-05 | 694 | 173 | 19 | IPR013087 |
| Domain | Somatotropin | 2.66e-05 | 7 | 173 | 3 | IPR001400 | |
| Domain | Cyt_P450_E_grp-I | 5.82e-05 | 45 | 173 | 5 | IPR002401 | |
| Domain | Tyr_kinase_rcpt_ROR | 8.53e-05 | 2 | 173 | 2 | IPR016247 | |
| Domain | zf-C2H2_6 | ZNF473 ZNF423 ZNF329 ZNF236 ZNF865 ZNF668 ZNF425 ZNF408 ZNF197 ZNF582 ZNF646 | 1.71e-04 | 314 | 173 | 11 | PF13912 |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 2.54e-04 | 3 | 173 | 2 | IPR006794 | |
| Domain | Zfx_Zfy_act | 2.54e-04 | 3 | 173 | 2 | PF04704 | |
| Domain | 4_helix_cytokine-like_core | 6.19e-04 | 74 | 173 | 5 | IPR009079 | |
| Domain | Prot_kinase_dom | STK36 HIPK4 CDK15 ROR1 ROR2 STYK1 TEX14 CIT STK16 MAP3K11 PRKCZ MAP3K13 TSSK1B | 6.51e-04 | 489 | 173 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | STK36 HIPK4 CDK15 ROR1 ROR2 STYK1 TEX14 CIT STK16 MAP3K11 PRKCZ MAP3K13 TSSK1B | 7.01e-04 | 493 | 173 | 13 | PS50011 |
| Domain | zf-C2H2 | ZNF473 ZNF423 ZNF329 ZBTB22 ZNF236 ZNF865 ZFY ZNF711 HINFP ZNF668 ZNF425 ZNF408 ZNF197 ZFHX3 ZNF582 ZNF646 | 7.34e-04 | 693 | 173 | 16 | PF00096 |
| Domain | Somatotropin_CS | 8.38e-04 | 5 | 173 | 2 | IPR018116 | |
| Domain | - | 1.01e-03 | 48 | 173 | 4 | 2.120.10.80 | |
| Domain | PROTEIN_KINASE_ATP | STK36 HIPK4 CDK15 ROR1 ROR2 STYK1 CIT STK16 MAP3K11 PRKCZ MAP3K13 TSSK1B | 1.21e-03 | 459 | 173 | 12 | PS00107 |
| Domain | Nuc_rcpt_coact | 1.25e-03 | 6 | 173 | 2 | IPR009110 | |
| Domain | Pkinase_Tyr | 1.29e-03 | 129 | 173 | 6 | PF07714 | |
| Pathway | REACTOME_EICOSANOIDS | 3.10e-08 | 12 | 120 | 5 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 3.10e-08 | 12 | 120 | 5 | MM14845 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 7.74e-08 | 14 | 120 | 5 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.15e-07 | 15 | 120 | 5 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.22e-07 | 18 | 120 | 5 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 3.22e-07 | 18 | 120 | 5 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.57e-06 | 11 | 120 | 4 | MM14863 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.91e-06 | 25 | 120 | 5 | MM14858 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 2.35e-06 | 12 | 120 | 4 | M27128 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 8.06e-06 | 33 | 120 | 5 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 8.06e-06 | 33 | 120 | 5 | MM15963 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.40e-05 | 62 | 120 | 6 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.68e-05 | 64 | 120 | 6 | M5650 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 1.75e-05 | 19 | 120 | 4 | MM1513 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.01e-05 | 66 | 120 | 6 | MM14839 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.67e-05 | 21 | 120 | 4 | M27137 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 4.87e-05 | 9 | 120 | 3 | M39819 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 6.46e-05 | 26 | 120 | 4 | MM1345 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 8.73e-05 | 28 | 120 | 4 | M47647 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 1.25e-04 | 12 | 120 | 3 | MM14777 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.62e-04 | 13 | 120 | 3 | MM14516 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.67e-04 | 61 | 120 | 5 | MM14861 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.58e-04 | 104 | 120 | 6 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.72e-04 | 105 | 120 | 6 | MM14842 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.11e-04 | 16 | 120 | 3 | MM15710 | |
| Pathway | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | 6.17e-04 | 20 | 120 | 3 | MM15070 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 8.23e-04 | 22 | 120 | 3 | MM1370 | |
| Pubmed | 4.11e-10 | 9 | 178 | 5 | 11087842 | ||
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 6.63e-10 | 4 | 178 | 4 | 18065749 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 ZXDC PHLDB3 STK36 MYCBP2 MYO7A POLE POLRMT AMBRA1 PFAS TSC2 CEP192 MLXIP ZNF236 ZNF865 CIT WIZ TRAPPC12 ZNF408 LRP4 MAP3K11 DTX2 EP300 RIC1 | 2.71e-09 | 1105 | 178 | 24 | 35748872 |
| Pubmed | 9.87e-09 | 6 | 178 | 4 | 9068972 | ||
| Pubmed | 2.29e-08 | 7 | 178 | 4 | 27771355 | ||
| Pubmed | 2.29e-08 | 7 | 178 | 4 | 18716208 | ||
| Pubmed | The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription. | 1.32e-07 | 3 | 178 | 3 | 12569362 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 8674830 | ||
| Pubmed | MKRN4P FOXO3 ZXDC NCOA3 TBX3 ZNF473 ZNF423 MKRN1 ZBTB22 SOX17 ZNF236 CLOCK HINFP ZNF668 WIZ NR0B1 ZFHX3 ZNF646 | 2.07e-07 | 808 | 178 | 18 | 20412781 | |
| Pubmed | 4.57e-07 | 13 | 178 | 4 | 18272476 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 FOXO3 HIPK4 TTC28 MYCBP2 IFT74 ROR2 TSC2 CEP192 MLXIP TAB3 ARHGEF1 RABGAP1L NCOA7 USP54 TSSK1B CSPP1 SEC23B | 5.21e-07 | 861 | 178 | 18 | 36931259 |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 5.25e-07 | 4 | 178 | 3 | 11185557 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 7169009 | ||
| Pubmed | 1.15e-06 | 16 | 178 | 4 | 10882104 | ||
| Pubmed | 1.15e-06 | 16 | 178 | 4 | 17567809 | ||
| Pubmed | Central growth hormone action regulates metabolism during pregnancy. | 1.31e-06 | 5 | 178 | 3 | 31479305 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 10767558 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 22969154 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 18006625 | ||
| Pubmed | AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis. | 1.31e-06 | 5 | 178 | 3 | 30513302 | |
| Pubmed | Growth hormone prevents the development of autoimmune diabetes. | 1.31e-06 | 5 | 178 | 3 | 24218587 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 9546108 | ||
| Pubmed | Transgene transmission to progeny by oMt1a-oGH transgenic mice. | 1.31e-06 | 5 | 178 | 3 | 16201410 | |
| Pubmed | Genes that prolong life: relationships of growth hormone and growth to aging and life span. | 1.31e-06 | 5 | 178 | 3 | 11487592 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 11318985 | ||
| Pubmed | Identification of the glomerular podocyte as a target for growth hormone action. | 1.31e-06 | 5 | 178 | 3 | 17272398 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 20707609 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 1.31e-06 | 5 | 178 | 3 | 21466787 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 1874564 | ||
| Pubmed | Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice. | 1.31e-06 | 5 | 178 | 3 | 32100023 | |
| Pubmed | Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. | 1.31e-06 | 5 | 178 | 3 | 10810296 | |
| Pubmed | Somatotropin transgenic mice have reduced jejunal active glucose transport rates. | 1.31e-06 | 5 | 178 | 3 | 7965203 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 17347312 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 21852148 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 12175649 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 15070902 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 14726450 | ||
| Pubmed | UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences. | 1.31e-06 | 5 | 178 | 3 | 24758742 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 10076541 | ||
| Pubmed | Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. | 1.31e-06 | 5 | 178 | 3 | 10594738 | |
| Pubmed | Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. | 1.31e-06 | 5 | 178 | 3 | 23639351 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 21098290 | ||
| Pubmed | Age-related changes in body composition of bovine growth hormone transgenic mice. | 1.31e-06 | 5 | 178 | 3 | 18948397 | |
| Pubmed | Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. | 1.31e-06 | 5 | 178 | 3 | 8496314 | |
| Pubmed | Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples. | 1.31e-06 | 5 | 178 | 3 | 21045135 | |
| Pubmed | Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice. | 1.31e-06 | 5 | 178 | 3 | 16508206 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 15616010 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 19019400 | ||
| Pubmed | The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH? | 1.31e-06 | 5 | 178 | 3 | 32556100 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 1525063 | ||
| Pubmed | Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. | 1.31e-06 | 5 | 178 | 3 | 11346667 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 12010633 | ||
| Pubmed | Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. | 1.31e-06 | 5 | 178 | 3 | 17626886 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 19359380 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 15316240 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 17301034 | ||
| Pubmed | Growth hormone action in the developing neural retina: a proteomic analysis. | 1.31e-06 | 5 | 178 | 3 | 18203262 | |
| Pubmed | Assignment of the porcine growth hormone gene to chromosome 12. | 1.31e-06 | 5 | 178 | 3 | 2249485 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 17242167 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 18180319 | ||
| Pubmed | Cloning and characterisation of the GH gene from the common dolphin (Delphinus delphis). | 1.31e-06 | 5 | 178 | 3 | 12225773 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 3780533 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 10395045 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 24190208 | ||
| Pubmed | Brief report: short stature caused by a mutant growth hormone. | 1.31e-06 | 5 | 178 | 3 | 8552145 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 36762426 | ||
| Pubmed | High molecular weight isoforms of growth hormone in cells of the immune system. | 1.31e-06 | 5 | 178 | 3 | 21741628 | |
| Pubmed | Structure of the growth hormone-encoding gene and its promoter in mice. | 1.31e-06 | 5 | 178 | 3 | 8647448 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 26887678 | ||
| Pubmed | The role of growth hormone in fetal mouse reproductive tract differentiation. | 1.31e-06 | 5 | 178 | 3 | 8756530 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 31099824 | ||
| Pubmed | Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. | 1.31e-06 | 5 | 178 | 3 | 1980158 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 17881271 | ||
| Pubmed | Neural growth hormone implicated in body weight sex differences. | 1.31e-06 | 5 | 178 | 3 | 23861378 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 12759574 | ||
| Pubmed | Growth hormone production and action in N1E-115 neuroblastoma cells. | 1.31e-06 | 5 | 178 | 3 | 19301152 | |
| Pubmed | Adipocyte insensitivity to insulin in growth hormone-transgenic mice. | 1.31e-06 | 5 | 178 | 3 | 11350075 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 18617616 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 11570960 | ||
| Pubmed | Promoter shuffling has occurred during the evolution of the vertebrate growth hormone gene. | 1.31e-06 | 5 | 178 | 3 | 10974531 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 23428905 | ||
| Pubmed | Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH. | 1.31e-06 | 5 | 178 | 3 | 17761891 | |
| Pubmed | 1.50e-06 | 17 | 178 | 4 | 12464179 | ||
| Pubmed | 1.65e-06 | 70 | 178 | 6 | 15128046 | ||
| Pubmed | NCOA3 TTC28 MYCBP2 CENPF IFT74 POLRMT WIZ GTF3C2 KIF15 NR0B1 ZFHX3 S100PBP | 1.87e-06 | 418 | 178 | 12 | 34709266 | |
| Pubmed | Mice lacking the orphan receptor ror1 have distinct skeletal abnormalities and are growth retarded. | 1.92e-06 | 18 | 178 | 4 | 20593419 | |
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 1.92e-06 | 18 | 178 | 4 | 33108146 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NUGGC CENPF MYO7A POLRMT MEI1 TTC19 KIF15 ZNF408 SEPTIN1 CSPP1 BAG6 TBL2 RIC1 | 1.93e-06 | 497 | 178 | 13 | 36774506 |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 12399427 | ||
| Pubmed | GH modulates hepatic epidermal growth factor signaling in the mouse. | 2.61e-06 | 6 | 178 | 3 | 20032199 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 11316754 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 23150490 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 2991252 | ||
| Pubmed | Third party data gene data set of eutherian growth hormone genes. | 2.61e-06 | 6 | 178 | 3 | 26697363 | |
| Pubmed | Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse. | 2.61e-06 | 6 | 178 | 3 | 15985453 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 20863500 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 12208853 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 9175714 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 16141391 | ||
| Interaction | NOTCH2 interactions | USP53 ZXDC RHBDD1 WNT2 ROR1 ROR2 STYK1 POLRMT ZNF865 SLIT2 ZNF668 RPUSD4 UMODL1 ZNF408 DTX2 ZNF646 | 7.96e-07 | 423 | 173 | 16 | int:NOTCH2 |
| Interaction | TOP3B interactions | FOXO3 ZXDC PHLDB3 STK36 MYCBP2 CENPF MYO7A POLE POLRMT AMBRA1 PFAS TSC2 APOB CEP192 MLXIP XRCC5 ZNF236 ZNF865 CIT WIZ TRAPPC12 ZNF408 MIB1 LRP4 MAP3K11 DTX2 KLHL14 EP300 SEC23B RIC1 | 7.70e-06 | 1470 | 173 | 30 | int:TOP3B |
| Cytoband | 17q24.2 | 2.15e-04 | 30 | 178 | 3 | 17q24.2 | |
| Cytoband | 2q35 | 2.62e-04 | 79 | 178 | 4 | 2q35 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZXDC ZNF473 ZNF423 ZNF329 ZBTB22 ZNF236 ZNF865 ZFY ZNF711 HINFP ZNF668 WIZ ZNF425 ZNF408 ZNF197 ZFHX3 ZNF582 ZNF646 | 7.15e-07 | 718 | 116 | 18 | 28 |
| GeneFamily | Cytochrome P450 family 4 | 3.21e-06 | 36 | 116 | 5 | 1003 | |
| GeneFamily | Growth hormone family | 5.08e-06 | 6 | 116 | 3 | 1175 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.64e-04 | 17 | 116 | 3 | 486 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.78e-03 | 10 | 116 | 2 | 53 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.14e-03 | 40 | 116 | 3 | 321 | |
| GeneFamily | Kelch like|BTB domain containing | 2.46e-03 | 42 | 116 | 3 | 617 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 1.83e-07 | 164 | 177 | 10 | M13108 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 1.65e-05 | 8 | 177 | 3 | M1766 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FOXO3 NCOA3 DMXL2 MAN2A1 TTC28 MYCBP2 CENPF ROR1 CLOCK CREB5 SLIT2 RSBN1 GTF3C2 PLPP3 RABGAP1L PIP5K1A ZFHX3 MN1 | 2.14e-05 | 856 | 177 | 18 | M4500 |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.01e-06 | 190 | 178 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-06 | 191 | 178 | 8 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.13e-06 | 193 | 178 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.27e-06 | 196 | 178 | 8 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-06 | 196 | 178 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.33e-06 | 157 | 178 | 7 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.45e-06 | 164 | 178 | 7 | 249d8f75a64bce7db52ce0c563f496b9edf602a6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-06 | 167 | 178 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.45e-06 | 184 | 178 | 7 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.45e-06 | 184 | 178 | 7 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 9.78e-06 | 185 | 178 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 186 | 178 | 7 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 188 | 178 | 7 | 61ae7405ab56570409bf35382dc0a038e4137c15 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-05 | 191 | 178 | 7 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-05 | 191 | 178 | 7 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 194 | 178 | 7 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.33e-05 | 194 | 178 | 7 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 129 | 178 | 6 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.38e-05 | 195 | 178 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 195 | 178 | 7 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.47e-05 | 197 | 178 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.47e-05 | 197 | 178 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.52e-05 | 198 | 178 | 7 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-05 | 134 | 178 | 6 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | Control-Mast_cells-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 4.67e-05 | 161 | 178 | 6 | 5807ee48f871a3eb24ebf78fd107cf5f2a4ec846 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 166 | 178 | 6 | 4b31d2755108b2815316411a38bfb11fd30ef98a | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 166 | 178 | 6 | 67370c49d7aedcb4eca802095f06b30f6bbf8919 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 166 | 178 | 6 | 7f4e5976ede6478636aa567d6fc2b56ff7295fb8 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 6.32e-05 | 170 | 178 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.53e-05 | 171 | 178 | 6 | f1fdc0ec3399ed6955976d02be7e5fc329a64276 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.53e-05 | 171 | 178 | 6 | 846a9acfff0bf0a9baf65dc07b7d7a9217ed6598 | |
| ToppCell | COVID-19_Mild-Neu_2|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 6.74e-05 | 172 | 178 | 6 | f5fd08b42c002d4693646b27e7b708eceb49524f | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 172 | 178 | 6 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.74e-05 | 172 | 178 | 6 | 30f4979abf0218618a56afb06aa6afc23ad838ec | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 173 | 178 | 6 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 173 | 178 | 6 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.19e-05 | 174 | 178 | 6 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.66e-05 | 176 | 178 | 6 | 8813c01ea080f373fe3970c5e1ba4c2dca0f7f02 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 177 | 178 | 6 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 177 | 178 | 6 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.15e-05 | 178 | 178 | 6 | 812e261d9cbdc74fafe3c5c3422151c1cfacb22d | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-immature_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.21e-05 | 182 | 178 | 6 | ab78df9de3878a6d67106a40094c893601de8076 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 9.49e-05 | 183 | 178 | 6 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 9.49e-05 | 183 | 178 | 6 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.78e-05 | 184 | 178 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.78e-05 | 184 | 178 | 6 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 185 | 178 | 6 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 185 | 178 | 6 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 185 | 178 | 6 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 185 | 178 | 6 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 186 | 178 | 6 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 186 | 178 | 6 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 186 | 178 | 6 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 186 | 178 | 6 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 187 | 178 | 6 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 187 | 178 | 6 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.07e-04 | 187 | 178 | 6 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 188 | 178 | 6 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.10e-04 | 188 | 178 | 6 | ecba5d06cbf3254448255a2aeefffe711f43310e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 188 | 178 | 6 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-04 | 188 | 178 | 6 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.10e-04 | 188 | 178 | 6 | 8cf135da4d1d2500755d2809d60b41509af9fa8b | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 189 | 178 | 6 | 610d7cc1fc923dbd67d3b71f94d529a658982f87 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-04 | 189 | 178 | 6 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 189 | 178 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 191 | 178 | 6 | 0f9443da0f73d07456142fae08b2dc92a5b7b592 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 191 | 178 | 6 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 192 | 178 | 6 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 192 | 178 | 6 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 192 | 178 | 6 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.23e-04 | 192 | 178 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.27e-04 | 193 | 178 | 6 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.27e-04 | 193 | 178 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-04 | 193 | 178 | 6 | cf680afddc08b6481f1b3eee9c57acfaebeac6f0 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 194 | 178 | 6 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 194 | 178 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-04 | 194 | 178 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.31e-04 | 194 | 178 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.31e-04 | 122 | 178 | 5 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.34e-04 | 195 | 178 | 6 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 195 | 178 | 6 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.34e-04 | 195 | 178 | 6 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 195 | 178 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 195 | 178 | 6 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.34e-04 | 195 | 178 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 195 | 178 | 6 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 195 | 178 | 6 | a838bddeed487154791b69d27a68673783ff63c0 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 196 | 178 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 196 | 178 | 6 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.38e-04 | 196 | 178 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.38e-04 | 196 | 178 | 6 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 196 | 178 | 6 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.42e-04 | 197 | 178 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.42e-04 | 197 | 178 | 6 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-04 | 197 | 178 | 6 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-04 | 197 | 178 | 6 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | distal-1-Hematologic-Basophil/Mast_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.42e-04 | 197 | 178 | 6 | e33752427eefeacbbc538e1b35f37194bdabfc40 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 197 | 178 | 6 | a41420d4b6d502c2f594c054c7efbb5d4eac83ff | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.42e-04 | 197 | 178 | 6 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| Drug | tienilic acid | 6.61e-07 | 93 | 177 | 8 | CID000038409 | |
| Drug | mephenytoin | 5.69e-06 | 88 | 177 | 7 | CID000004060 | |
| Drug | aminoglutethimide | 1.21e-05 | 137 | 177 | 8 | CID000002145 | |
| Drug | propoxyphene | 1.37e-05 | 67 | 177 | 6 | CID000010100 | |
| Drug | Sparteinum | 1.42e-05 | 101 | 177 | 7 | CID000003966 | |
| Drug | C 15 | 1.58e-05 | 7 | 177 | 3 | CID003014700 | |
| Drug | carteolol | 2.07e-05 | 72 | 177 | 6 | CID000002583 | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 6352_DN | |
| Drug | tolbutamide | CYP7A1 CYP4F2 ADCY3 ADCY8 CYP4A22 AGL CYP4F3 CYP4F12 CYP4F11 | 2.58e-05 | 198 | 177 | 9 | CID000005505 |
| Drug | Bisoprolol fumarate; Down 200; 9uM; HL60; HT_HG-U133A | GOSR1 AMBRA1 MLXIP HINFP WIZ ARHGEF1 NUP210 ST6GALNAC4 CSPP1 | 2.58e-05 | 198 | 177 | 9 | 1287_DN |
| Drug | halothane | CYP7A1 CYP4F2 ADCY3 ADCY8 CHRNB2 CYP4A22 CYP4F3 CYP4F12 PRKCZ CYP4F11 ATP2B2 | 3.69e-05 | 314 | 177 | 11 | CID000003562 |
| Drug | trimipramine | 3.78e-05 | 80 | 177 | 6 | CID000005584 | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 1.96e-06 | 5 | 173 | 3 | DOID:0060872 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 6.81e-06 | 7 | 173 | 3 | DOID:0060870 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 3.16e-05 | 11 | 173 | 3 | DOID:0050564 (is_implicated_in) | |
| Disease | Ciliopathies | 4.82e-05 | 110 | 173 | 6 | C4277690 | |
| Disease | Polydactyly | 6.80e-05 | 117 | 173 | 6 | C0152427 | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 6.88e-05 | 14 | 173 | 3 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | height-adjusted body mass index | 1.02e-04 | 3 | 173 | 2 | EFO_0005851 | |
| Disease | Adenocarcinoma of large intestine | 2.60e-04 | 96 | 173 | 5 | C1319315 | |
| Disease | cigarettes per day measurement | ZNF423 AMBRA1 ADCY3 CREB5 ADCY8 CHRNB2 ZNF668 ZNF408 RABGAP1L TBL2 | 2.78e-04 | 438 | 173 | 10 | EFO_0006525 |
| Disease | osteoporosis (biomarker_via_orthology) | 2.81e-04 | 22 | 173 | 3 | DOID:11476 (biomarker_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 4.02e-04 | 227 | 173 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | suicidal ideation | 6.47e-04 | 29 | 173 | 3 | EFO_0004320 | |
| Disease | COVID-19, obesity | 7.04e-04 | 7 | 173 | 2 | EFO_0001073, MONDO_0100096 | |
| Disease | response to ketamine | 7.33e-04 | 69 | 173 | 4 | EFO_0009748 | |
| Disease | level of Triacylglycerol (49:2) in blood serum | 9.35e-04 | 8 | 173 | 2 | OBA_2045162 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 1.20e-03 | 9 | 173 | 2 | EFO_0800562 | |
| Disease | glioblastoma (implicated_via_orthology) | 1.20e-03 | 9 | 173 | 2 | DOID:3068 (implicated_via_orthology) | |
| Disease | Nonsyndromic Deafness | 1.34e-03 | 81 | 173 | 4 | C3711374 | |
| Disease | Obesity | 1.36e-03 | 205 | 173 | 6 | C0028754 | |
| Disease | Odontome | 1.49e-03 | 10 | 173 | 2 | C0524730 | |
| Disease | Tooth Abnormalities | 1.49e-03 | 10 | 173 | 2 | C0040427 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 1.55e-03 | 39 | 173 | 3 | DOID:9744 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | NCOA3 TPTE TBX3 CENPF ROR1 ZNF668 TRAPPC12 SNX32 FGD5 DLEC1 MAP3K13 USP54 EP300 ZNF646 FOXP3 | 1.71e-03 | 1074 | 173 | 15 | C0006142 |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.79e-03 | 147 | 173 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.79e-03 | 41 | 173 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.79e-03 | 41 | 173 | 3 | C0858252 | |
| Disease | lysophosphatidylcholine 20:2 measurement | 1.82e-03 | 11 | 173 | 2 | EFO_0021458 | |
| Disease | nasopharyngeal neoplasm | 2.01e-03 | 151 | 173 | 5 | EFO_0004252 | |
| Disease | level of Ceramide (d42:2) in blood serum | 2.17e-03 | 12 | 173 | 2 | OBA_2045186 | |
| Disease | cortical thickness | FOXO3 FBXL13 MYCBP2 ZNF423 ROR1 ADGRV1 CLOCK SLIT2 UMODL1 FAM107B LRP4 DLEC1 PRKCZ ATOH1 CPEB1 | 2.41e-03 | 1113 | 173 | 15 | EFO_0004840 |
| Disease | amenorrhea, response to antineoplastic agent | 3.41e-03 | 15 | 173 | 2 | EFO_0010269, GO_0097327 | |
| Disease | decreased susceptibility to hepatitis C infection | 3.89e-03 | 16 | 173 | 2 | EFO_0010101 | |
| Disease | Diabetic Angiopathies | 3.89e-03 | 16 | 173 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 3.89e-03 | 16 | 173 | 2 | C0025945 | |
| Disease | heart disease (biomarker_via_orthology) | 4.39e-03 | 17 | 173 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | Breast Carcinoma | 4.64e-03 | 538 | 173 | 9 | C0678222 | |
| Disease | androstenedione measurement, estrone measurement | 4.92e-03 | 18 | 173 | 2 | EFO_0007970, EFO_0007972 | |
| Disease | brain measurement, neuroimaging measurement | 5.34e-03 | 550 | 173 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | hydrocephalus (implicated_via_orthology) | 5.47e-03 | 19 | 173 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | FOXO3 GOSR1 TSC2 APOB MLXIP ADCY3 CREB5 ADCY8 GH1 CSH1 SNX32 SLIT1 MAP3K11 ZFHX3 | 5.77e-03 | 1106 | 173 | 14 | EFO_0021796 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QVDPRLLNHMRLLHS | 186 | Q5DID0 | |
| HNENMLRNILPSHVA | 946 | P40145 | |
| NHNTMPSQFRDILRR | 2171 | Q09472 | |
| RTHFIDHDRPMNTLT | 496 | Q8IWZ6 | |
| HVRMLRVLHDLFFQP | 431 | Q92888 | |
| QLRNDHMNLRGHTPL | 421 | Q7Z7A1 | |
| LPMAQEIFRLSRHHI | 231 | Q96FG2 | |
| DVVMLLHGHFQPLQR | 766 | P46379 | |
| IRGLPLHHRMFATQT | 16 | Q53S33 | |
| GIFPTTVHLQQHMRR | 1306 | Q8WXG9 | |
| QMIRLHVQRLFGFHS | 5021 | Q8WXG9 | |
| QNHDIMHAIISPLRS | 436 | Q5W041 | |
| SELFRLAAHPLNNRM | 2366 | Q8TDJ6 | |
| RLEMNSNPLHFRVEN | 4626 | Q96M86 | |
| RTPLLHNFLHMLSSR | 236 | Q9C0C7 | |
| LLHPSTEHMVAQVFR | 966 | Q9C0C7 | |
| METALRQFAAHPEHQ | 146 | Q6UXS9 | |
| RMHHNIPHRFNVGLN | 1356 | O14578 | |
| RTSIHNFMAHPEFRI | 1161 | Q01814 | |
| PFINSHEIRSMILHL | 141 | Q8N123 | |
| LQVLHPMDAAQRSQH | 276 | Q13434 | |
| PEHTMSHINFRLALI | 476 | Q96DM1 | |
| LMHRDSFPRFLNSQI | 181 | Q9UGC6 | |
| HSFLSQRIMLPFHIN | 761 | Q4ADV7 | |
| HLPSHAQDMLDGLQR | 11 | Q0D2K2 | |
| MNATFLRGHIQRRHA | 176 | Q8IYY4 | |
| RIMARHLHPIQTSFQ | 1556 | Q8TEM1 | |
| IHPDIAHMERLLQQA | 451 | Q6NSJ2 | |
| LSSLLHLHNRQRQPM | 161 | Q02930 | |
| IFSAVRLDTHLHNPM | 61 | Q8NGY3 | |
| VPLTIQLTHQFFHRM | 2011 | Q14667 | |
| NAALMHTLQRHRDIL | 101 | O95249 | |
| SERHMHVQLQLDNLR | 836 | Q9NS87 | |
| AVTENMRVPHFLQDH | 481 | Q8NCT3 | |
| LNRAGLSHMLIQRVH | 301 | Q16706 | |
| LQDRPHFMHQLSTVD | 96 | Q9BZS1 | |
| ALRHPFVSMQQLRSA | 341 | Q8NE63 | |
| SHDLPRRHSMDRQNS | 236 | Q9UBI9 | |
| RNMYHQFDRTLHPRQ | 496 | Q9Y217 | |
| TMRAVRRHLFPQHSA | 91 | Q86UW9 | |
| PLSRLFDHAMLQAHR | 31 | P0DML3 | |
| MIQHLHRDNDNVPRI | 46 | Q96MA6 | |
| FMIANINHHRPQFLE | 1436 | Q9NYQ8 | |
| IQHMNLRLLSDRNHE | 611 | Q9HCI6 | |
| LNRMHRQNIDAYHNP | 691 | Q1MSJ5 | |
| AQKHSFPRMLHQRER | 126 | Q8TEB1 | |
| RQFHFAGIRSRLNHM | 531 | Q9H4H8 | |
| LQHLNLDFHGAVMRA | 911 | Q6ZNL6 | |
| MPRVLRHRHLAQCLQ | 511 | Q8N2G8 | |
| DPRMNLFHISIHQQQ | 191 | P12525 | |
| LAAMLPAQRHRHLLF | 51 | Q8TD35 | |
| LRALFHMNILLPDSH | 561 | P59047 | |
| MPASRSEYHRIQHQL | 676 | Q07864 | |
| LMSIHNIDHAQREPL | 326 | Q99755 | |
| ERLMQEQLPDLHSHF | 671 | Q5R372 | |
| HHAALRGNPSAMRVL | 601 | Q86YT6 | |
| RHLEQTTHPALMEVF | 561 | Q5TIA1 | |
| RMTHQGPHDRFIELN | 416 | P51843 | |
| HLQFRFHPQRMIISR | 586 | E5RHQ5 | |
| RHDMPDRTLAAHQQK | 61 | Q8IZS5 | |
| NRPSFRQTLMHLDIA | 396 | O43283 | |
| PRRQQIIHSGHFMVS | 71 | Q9HAP2 | |
| FPLSAMLEAHRRQRH | 121 | Q96IJ6 | |
| LLDHRVPQTDMTFRH | 1211 | P04114 | |
| LHQERMILSTHRNAF | 501 | Q96LB3 | |
| QLHMFAPRHVNLSSL | 1051 | Q86XA9 | |
| LQQLHMFAPRHVNLS | 1051 | Q9P2D3 | |
| IHRHALNMRRVPSSQ | 691 | Q9NVR0 | |
| HLMPFRQHCRQSLAS | 301 | Q9P2G3 | |
| EHPDAVRQLHMEFLR | 51 | Q9H2M3 | |
| RNMPEILHHLTTDRN | 236 | Q96SD1 | |
| TLPQATMNHRDIARH | 196 | P49454 | |
| QRSLLAFDQQPAMHH | 781 | P49454 | |
| LHPHNVRLFMFQLLR | 196 | Q96Q40 | |
| TSRNHQDLHRELLMN | 26 | Q9H098 | |
| RHRRMLTPAFHFNIL | 146 | Q9HBI6 | |
| QHRRMLTPAFHNDIL | 141 | Q5TCH4 | |
| RMQRLAREHGSHPVQ | 206 | P23610 | |
| NLLTHHRRNTSMEPA | 226 | Q53FE4 | |
| RHRRMLTPAFHFNIL | 146 | Q9HCS2 | |
| RMHGLNHAFDQLRNV | 171 | Q92858 | |
| FDRVNMHNLLIHLVR | 101 | Q5T5S1 | |
| HRQVQDRMVPSAHNR | 296 | Q8IYS4 | |
| LVTNMLPEHVARHFL | 891 | O60266 | |
| FQRELRQVHMKRPHS | 446 | O15033 | |
| RHRRMLTPAFHFNIL | 146 | P78329 | |
| RTMRLLPRHFHNLQN | 286 | Q8NEE6 | |
| RIHAPRDLQTMHFLA | 1646 | Q8TEP8 | |
| AGLPIHMFRTAHNAR | 221 | P22680 | |
| RHHSPLMRNQKNRDS | 551 | Q9BZB8 | |
| RHRRMLTPAFHFNIL | 146 | Q08477 | |
| RFLAQFPVHQQMRLH | 861 | P57679 | |
| LMHRRHTDPVQLQAA | 256 | O75791 | |
| LPSSLRNHMRFRHSE | 266 | Q9BQA5 | |
| PLSRLFDHAMLQAHR | 31 | P0DML2 | |
| NFQIEHHLFPRMPRH | 381 | Q9Y5Q0 | |
| SPHELRDFHSVLQMV | 701 | Q9Y238 | |
| AHRMQPHRLKAFFNQ | 271 | Q1HG43 | |
| RNMRSHHRFQRLPDF | 391 | Q96BU1 | |
| AQHLRDRVFWLPHNM | 786 | O00411 | |
| VRQEARLFAMLAHPN | 161 | Q16584 | |
| LQVLHPMDAAQRSQH | 241 | Q9UHC7 | |
| QFEYPIHRLENRSMH | 406 | Q10571 | |
| RHNLSLHSRFMRVQN | 211 | O43524 | |
| HSLHRLRLEMPNEDQ | 351 | Q96CM3 | |
| PFMTHQEHSIRRNFL | 336 | Q5VWQ0 | |
| AERLRVQHMQDHPNY | 121 | Q9H6I2 | |
| LPNEHLHMSVLRRFA | 481 | Q68CJ6 | |
| RLRLHSFMLPCNHSL | 151 | Q8IWZ5 | |
| GFHLSPEEMRRQRLH | 296 | Q8TEB9 | |
| SVLHERRSQFPVLHM | 336 | Q8IWB6 | |
| RRSQFPVLHMEVIVH | 341 | Q8IWB6 | |
| SSVHRHPFLNLNTMR | 621 | O15119 | |
| EAQREADMHRLFNHP | 61 | O75716 | |
| ADMHRLFNHPNILRL | 66 | O75716 | |
| MNRNRLLHINLGIHS | 66 | Q8N5C8 | |
| HFHRSTLRNLQGNPM | 151 | Q7Z3H4 | |
| YHRIVQQRMQHSPDL | 66 | Q9NW38 | |
| LRPHSALLENMHIEQ | 776 | Q8NI08 | |
| LSPVDIIDRNNHHNM | 296 | O14495 | |
| LLIHRPSERQDNHGM | 471 | Q8TC59 | |
| RELLSHHFRQQRVAM | 1231 | Q9Y6Q9 | |
| RMFEQHHPRSFNLNT | 26 | A0A1B0GU33 | |
| FRHRPQEAFREALHM | 471 | Q9NSC7 | |
| FMNHREQALARLRSH | 886 | O75592 | |
| HLLEHMSQHRRAPGQ | 281 | O95785 | |
| FRHEAMLRARLQHPN | 521 | Q01974 | |
| SRVAQMHSLFRHLFP | 296 | A6NJG2 | |
| LYTPNHRHLMVRLNS | 26 | Q9BUU2 | |
| RHHFARQDLTQSLIM | 606 | Q15437 | |
| RGLRHPNIVHMLDSF | 56 | Q9NRP7 | |
| RIQVEHPQMTFGRLH | 91 | Q16384 | |
| LLFMQQPRHHCARQR | 346 | P17787 | |
| VAMTFHLQHRAQSPL | 586 | Q7Z7M1 | |
| HLPAHEKMVQRRSSF | 466 | O15516 | |
| IQDFMFHGIHLPRRS | 286 | Q86XI2 | |
| NMLERIHFHIVPSRD | 126 | Q70EK8 | |
| NQGDLHEFLIMRSPH | 556 | Q01973 | |
| NPHHCDFLNLRRMLV | 261 | Q8WYJ6 | |
| HLFHGDVAARNILMQ | 246 | Q6J9G0 | |
| SDLARQINHPELHMV | 306 | Q6DKK2 | |
| HNRVVRIMIDDHNVP | 296 | P56180 | |
| QMYLAHEQAPRSAHR | 261 | Q9H4F1 | |
| QRQLCHRHPDVMRAI | 51 | P09544 | |
| GFIQRSSLLMHLRNH | 406 | O14709 | |
| ALLMRHQRCHTEQRP | 861 | P0CJ78 | |
| TVTLEPLAMHQRHFQ | 321 | Q7Z2Z1 | |
| HMVRQHSRRQDLLPQ | 471 | Q2QGD7 | |
| DFRQPADLAMHRRVH | 316 | Q96K58 | |
| QLEAMVQQDPRHYLH | 676 | Q8WVT3 | |
| ALATLHDRMTEQHFP | 141 | O15067 | |
| RNFLSRNRLMITHHA | 111 | Q8TBR7 | |
| PLANQGSLRNHMRLH | 476 | Q9H9D4 | |
| YPNLMALRNHVRVHC | 501 | O15015 | |
| HLFHNRSVLADQMRL | 396 | P52849 | |
| FDNAMLRAHRLHQLA | 36 | P01241 | |
| LFVHRFSHGTMPLRN | 146 | Q9NZ01 | |
| NHMPKLRTFRLHSNN | 196 | O94813 | |
| HSSFRRHLPRQMQVS | 171 | Q6XYQ8 | |
| QQGNPDRHFHQMIIR | 131 | Q96NG8 | |
| REALTNHRHQLVLAM | 291 | Q96AY4 | |
| HMLQPDVNRRLHIDE | 251 | Q9BXA7 | |
| MHQTHAIQRLEVLPS | 1 | Q6ZS52 | |
| QFQRHMRDHERNDKP | 51 | Q9UL36 | |
| FRHHPQLSAMIRGQD | 256 | Q8N831 | |
| SPLGHRMQLESRAHF | 871 | Q8WUA4 | |
| TMEVLLQNHRLRDHN | 896 | Q2M1K9 | |
| MLQHFRQLNSPLHGL | 231 | O60294 | |
| GFRRPSEKNQHIMRH | 741 | Q9Y462 | |
| AMHEVFLQRLAAHPT | 136 | Q86XE0 | |
| FNHMPKLRTFRLHSN | 201 | O75093 | |
| AMRAHQRLHSEQKPF | 456 | Q6IV72 | |
| LVRHQRAHLGEQPME | 526 | Q86UD4 | |
| VRLFHNTPGHRAMVE | 396 | Q9Y4P3 | |
| DRHVNMHLNLRPFDC | 501 | O15209 | |
| YRQRAHSNPMADHTL | 21 | Q9UBP6 | |
| PAMHFVDHSLQVVRL | 261 | Q6X784 | |
| NITVHRHLMLPDFDL | 76 | P13010 | |
| RNLPFVARQMALHAN | 1706 | P49815 | |
| FRRPSEKNQHIMRHH | 781 | P08048 | |
| RSFSRPSHLMRHQAI | 466 | Q8WTR7 | |
| NRLRVHAMTQHSVQP | 1236 | Q15911 | |
| HLLEQHPRLIQRMES | 646 | Q70EL1 | |
| IPALIENDHHMNSIR | 271 | P35573 | |
| HMQRQRKLPEEHARF | 341 | Q05513 | |
| LENLMDIHVFHRRRP | 986 | O75096 | |
| LEQMERARHEPVNHS | 926 | Q13402 |